Overview
Bruce Hershatter is a Radiation Oncologist in Atlanta, Georgia. Dr. Hershatter has been practicing medicine for over 44 years is highly rated in 6 conditions, according to our data. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, and Prostatectomy.
His clinical research consists of co-authoring 25 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5673 Peachtree Dunwoody Road, Fl3, Atlanta, GA 30342
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Emory Winship Cancer Institute
Hui-kuo Shu is a Radiation Oncologist in Atlanta, Georgia. Dr. Shu has been practicing medicine for over 33 years is highly rated in 30 conditions, according to our data. His top areas of expertise are Glioblastoma, Astrocytoma, Brain Tumor, and Glioma.
Emory Winship Cancer Institute
Ashesh Jani is a Radiation Oncologist in Atlanta, Georgia. Dr. Jani has been practicing medicine for over 31 years is highly rated in 6 conditions, according to our data. His top areas of expertise are Prostate Cancer, Muscle Invasive Bladder Cancer, Familial Prostate Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Prostatectomy.
Emory Winship Cancer Institute
Jim Zhong is a Radiation Oncologist in Atlanta, Georgia. Dr. Zhong is highly rated in 20 conditions, according to our data. His top areas of expertise are Astrocytoma, Meningioma, Glioblastoma, Splenectomy, and Pancreaticoduodenectomy.
Frequently Asked Questions about Dr. Bruce Hershatter
How do I make an appointment with Dr. Bruce Hershatter?
You can book an appointment with Dr. Bruce Hershatter by calling their office at 404-778-1900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Bruce Hershatter a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Bruce Hershatter is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Bruce Hershatter specialize in?
While Dr. Bruce Hershatter is a Radiation Oncology, they have specific expertise in Prostate Cancer, Familial Prostate Cancer, and Non-Muscle Invasive Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.
Does Dr. Bruce Hershatter participate in research or clinical trials?
Yes. Dr. Bruce Hershatter has published 25 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Bruce Hershatter's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Bruce Hershatter accept my insurance?
Dr. Bruce Hershatter accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 404-778-1900 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Prostate CancerDr. Hershatter isDistinguished. Learn about Familial Prostate Cancer.
- Prostate CancerDr. Hershatter isDistinguished. Learn about Prostate Cancer.
- Advanced
- Muscle Invasive Bladder CancerDr. Hershatter isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Hershatter isAdvanced. Learn about Non-Muscle Invasive Bladder Cancer.
- Pleuropulmonary BlastomaDr. Hershatter isAdvanced. Learn about Pleuropulmonary Blastoma.
- ProstatectomyDr. Hershatter isAdvanced. Learn about Prostatectomy.
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Hershatter isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Alveolar Soft Part SarcomaDr. Hershatter isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Anal CancerDr. Hershatter isExperienced. Learn about Anal Cancer.
- Bone TumorDr. Hershatter isExperienced. Learn about Bone Tumor.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Hershatter isExperienced. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- EGFR Positive Lung CancerDr. Hershatter isExperienced. Learn about EGFR Positive Lung Cancer.